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Antibiotic resistance is a key medical concern, with
antibiotic use likely being an important cause. How-
ever, here we describe an alternative route to clini-
cally relevant antibiotic resistance that occurs solely
due to competitive interactions among bacterial
cells. We consistently observe that isolates of
Methicillin-resistantStaphylococcus aureus diversify
spontaneously into two distinct, sequentially arising
strains. The first evolved strain outgrows the parent
strain via secretion of surfactants and a toxic bacte-
riocin. The second is resistant to the bacteriocin.
Importantly, this second strain is also resistant to in-
termediate levels of vancomycin. This so-called VISA
(vancomycin-intermediate S. aureus) phenotype is
seen in many hard-to-treat clinical isolates. This
strain diversification also occurs during in vivo in-
fection in a mouse model, which is consistent with
the fact that both coevolved phenotypes resemble
strains commonly found in clinic. Our study shows
how competition between coevolving bacterial
strains can generate antibiotic resistance and reca-
pitulate key clinical phenotypes.
INTRODUCTION
Antibiotics are the primary treatment for bacterial infections.
However, the number of effective antibiotics is decreasing due
to the rising numbers of multi-drug-resistant pathogens. The
path to resistance generally involves the acquisition of specific
mutations that enable bacteria to grow in the presence of the an-
tibiotics recommended for their treatment (Canto´n andMorosini,
2011). However, the development of antibiotic resistance is also
a naturally occurring process in bacteria, which is not exclusively
restricted to clinically relevant species (Benveniste and Davies,
1973). For example, bacteria in the environment may secrete1060 Cell 158, 1060–1071, August 28, 2014 ª2014 Elsevier Inc.antibiotics to remove niche competitors. These bacteria them-
selves harbor genes enabling them to resist their own antimi-
crobials (Allen et al., 2010), and in turn, they exert a selective
pressure on neighboring bacteria to acquire mutations or trans-
ferred genes that are protective (Hibbing et al., 2010). This raises
the possibility that the rising levels of antibiotic resistance in
pathogens may also be influenced by competitive microbial in-
teractions, similar to what occurs in natural environments.
Multi-drug-resistant strains are becoming more and more
prevalent in the hospital environment, and as a consequence,
they are increasingly responsible for nosocomial infections.
One of the most threatening hospital-associated pathogens is
the bacterium Staphylococcus aureus, which currently repre-
sents a major problem in both the clinical and community set-
tings. However, S. aureus is not exclusively a pathogen and
commonly colonizes the nasopharynx and skin (Kluytmans
et al., 1997). Nevertheless, most of these strains have the capac-
ity to cause severe infections when associated with bones and
soft tissues, which occasionally progress to life-threatening dis-
eases such as necrotizing fasciitis or pneumonia (Otto, 2012).
Moreover, due to the widespread use of the antibiotic methicillin
in the 1960s, several strains exist that are resistant to a wide
range of b-lactam antibiotics, known as methicillin-resistant
S. aureus or MRSA (Kreiswirth et al., 1993). MRSA infections
are difficult to treat, with a mortality rate of 20%, and are the
leading cause of death by a single infectious agent in the USA,
being responsible for more deaths than HIV (Klevens et al.,
2007). More recently, a subset of community-associated
MRSA (CA-MRSA) strains has emerged that, in addition to being
resistant to multiple antibiotics, is no longer restricted to clinical
settings and has the ability to cause severe and pandemic infec-
tions in healthy individuals (Diep et al., 2008). The traditional
approach to treat MRSA and CA-MRSA infections has been
the glycopeptide vancomycin, and therefore, it is a common
treatment for staphylococcal infections. However, the general
use of the antibiotic has led to the emergence of several strains
that display reduced susceptibility to vancomycin (Hiramatsu
et al., 1997). These strains are commonly referred to as vanco-
mycin-intermediate S. aureus (VISA), and although their level of
resistance is relatively moderate (MIC = 4–8 mg/ml) in compari-
son to strains that are fully resistant to vancomycin (vancomycin
resistance S. aureus, VRSA) (MICR 16 mg/ml), due to their prev-
alence, VISA strains represent a major threat to overcoming
staphylococcal infections (Howden et al., 2010).
The antibacterial activity of vancomycin relies on its capacity
to bind to and inactivate certain precursors of cell wall synthesis,
whichexclusively localize at thedivision septum inS. aureus (Per-
eira et al., 2007). S. aureus strains acquire intermediate resis-
tance to vancomycin treatment via the acquisition of point muta-
tions in regulatory genes that lead to the thickeningof thecellwall.
This provides a protective barrier against the diffusion of vanco-
mycin to its target at the division septum (Howden et al., 2010;
Pereira et al., 2007). VISA strains emerge from vancomycin-sus-
ceptible strains during infections treated with the antibiotic (Hira-
matsu et al., 1997), and in contrast to the rare cases of VRSA
infections, VISA strains cause numerous difficult-to-treat, hospi-
tal-associated infections. However, it is also puzzling that VISA
strains have been detected in patients with renal failure or a pros-
thetic joint that have not been treated with vancomycin (Charles
et al., 2004; Howden et al., 2010). These infections are usually
associated with high-cell-density bacterial colonization, which
is currently considered one of the risk factors that promotes the
occurrence of VISA (Charles et al., 2004; Howden et al., 2010).
Bacterial colonization at high cell density involves prolonged
periods of infection and the formation of surface-associated ag-
gregates or biofilms (Lo´pez et al., 2010). Biofilm formation is a
key feature of staphylococcal infections, in addition to the secre-
tion of virulence factors (Herbert et al., 2010). The agr quorum-
sensing (QS) system of S. aureus controls the infection process
by upregulating virulence factors, such as membrane-disrupting
toxins (Hla, Hlb, and Hlg), proteases, lipases, enterotoxins,
superantigens, and urease while at the same time indirectly
downregulating the extracellular matrix and adhesin proteins
responsible for cell aggregation and biofilm formation (Boles
and Horswill, 2008; Peng et al., 1988; Recsei et al., 1986). Impor-
tantly, agr is repressed by thesB stress-induced sigma factor.sB
is activated during biofilm formation in response to cellular stress
and triggers the expression of a general stress response regulon
that includes genes associated with pigmentation and biofilm
formation (Bischoff et al., 2001; Kullik et al., 1998).
A growing body of empirical and theoretical work suggests that
biofilm-encasedcells are subjected to strongnatural selection, as
they compete for space and nutrients, which can shapemicrobial
phenotypes and diversity (Nadell et al., 2009). These conditions
give rise to a heterogeneous population of genetically different
bacteria that display characteristics that are relevant to under-
standing the progression of an infection. We hypothesized that
a biofilm environment of a single staphylococcal clone could be
a factor shaping the diversity of MRSA strains in which the path-
ogen could evolve new phenotypes that resist antibiotic treat-
ment. This report presents evidence for an unexpected route to
the evolution of antibiotic resistance in staphylococcal commu-
nities thatoccurswithout theselectivepressureof antibiotic treat-
ment but solely via intraclonal competitive interactions between
bacterial cells. Microbial aggregates of a single staphylococcal
isolate spontaneously evolved new competitive phenotypes in a
coevolutionary arms race that ultimately led to the emergenceof an intermediate resistant phenotype similar to VISA clinical iso-
lates. Our study provides evidence for how bacterial interactions
play an important role in microbial evolution and may serve to
explain the diversification of key clinical phenotypes.
RESULTS
Strain Diversification in Staphylococcal Biofilms
The genetic basis of biofilm formation in S. aureus has been
routinely explored using submerged surfaces in tryptone soy
broth (TSB) medium + NaCl 500 mM (Beenken et al., 2003;
Go¨tz, 2002). However, to study the diversification and evolution
of new strains, we established a biofilm formation assay in
S. aureus using solid agar (Branda et al., 2001). The assay utilized
Mg2+-enriched conditions because previous studies have shown
that chronic staphylococcal infections due to biofilm formation
occur in niches contain a high concentration of Mg2+ (e.g., joints
or bones) (Gu¨nther, 2011; Jahnen-Dechent, 2012), whereas tis-
sues unintentionally depleted of Mg2+ are prone to acute staph-
ylococcal infections (Schlievert, 1985). S. aureus strains were
grown on TSB + 100 mM MgCl2 solid agar (tryptone soy broth
supplemented with magnesium, TSBMg) for 5 days. After incu-
bation, staphylococcal communities developed into robust ag-
gregates with a complex architecture in which immobilized cells
became encased within an extracellular matrix, as reported for
other species (Branda et al., 2001; Serra et al., 2013) (Figures
1A, S1A, and S1B available online). When extending this assay
to clinical isolates, we observed morphological diversity (Fig-
ure S1C), and a number of strains (SC01, RN1, N315, LAC,
and HG003 strains) reproducibly developed distinct sectors
that were phenotypically different to the parental strain as the
colonies grew across the plate (Figures 1A and S1C) (Servin-
Massieu, 1961). The development of the distinct sectors is
consistent with the appearance of S. aureus variants that display
a competitive advantage during growth.
To gain insight into the evolution of these new variants and
their potential roles in biofilm formation during clinically relevant
infections, we focused on a CA-MRSA clinical isolate (SC01 de-
rivative) that displayed the most evident sectoring phenotype
among all strains tested. Thewild-type (WT) strain initially formed
an orange-colored center region or origin (O). The orange color
comes from the carotenoid pigment staphyloxanthin, which is
responsible for the golden coloration of S. aureus (Marshall
and Wilmoth, 1981). Over time, a second unpigmented strain
emerged that is white (W) and rapidly surrounded the origin. Sub-
sequently, a third strain emerged, forming yellow flares (Y) that
radiated from the origin and through the white sector to generate
a distinctive flower-like distribution pattern of cells within the
bacterial community (Figures 1B and S1D). Diversification of W
and Y phenotypes strongly depended on the presence of Mg2+
in the medium and occurred in both liquid culture and solid
agar biofilm assays (Figures S1E and S2A).
When isolated and reinoculated, O cells developed a similar
distribution of alternating sectors of nonpigmented and pale yel-
low pigmented cells. However, isolation and reinoculation of W
and Y cells resulted in a homogeneous community (Figure 1B).
In addition to the differences in pigmentation, O cells displayed
an increased ability to form biofilms in the conventional biofilmCell 158, 1060–1071, August 28, 2014 ª2014 Elsevier Inc. 1061
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Figure 1. Strain Diversification in Commu-
nities of S. aureus
(A) S. aureus SC01 derivative strain grown in TSB
and TSBMg for 5 days at 37C.
(B) Progression of O, W, and Y strains when
growing in TSBMg for 5 days at 37C. Scale bars,
1 mm.
(C) Measurements of Staphyloxanthin production,
biofilm formation, and secretion of hemolytic toxins
in O, W, and Y strains. C+ is LAC strain, and C- is
LAC DsB mutant. Hemolysis efficiency used LAC
DsB mutant as a C+, and C- is LAC strain.
(D) qRT-PCR of the expression staphyloxanthin
production (crt), biofilm formation (ica and spa),
and hemolytic toxins (hla) in O, W, and Y strains in
TSB and TSBMg growing media (Student’s t test,
p% 0.05).
See Figures S1 and S2.formation assay and a low ability to secrete hemolytic toxins (Fig-
ure 1C). W cells showed the opposite biological activities and
Y cells displayed an intermediate response in the collection of
assays that we performed. Furthermore, quantitative RT-PCR
(qRT-PCR) analyses verified that these differences were associ-
ated with changes in expression of key genes involved in these
processes (Figures 1D and S2B). Pigment production, biofilm
formation, and hemolysis directly correlated with the expression
of staphyloxanthin (crt) (Pelz et al., 2005), biofilm-related genes
(ica and spa genes) (O’Gara, 2007; Otto, 2008), and hemolytic
toxin genes (hla) (Brown and Pattee, 1980), respectively, sug-
gesting that O, W, and Y strains are physiologically distinct.
W Strain Displays a Hyperactive QS Phenotype
The phenotypic characterization of the initial O strain displaying
increased biofilm production and decreased toxin secretion sug-
gested that the QS system was repressed because agr QS sys-
tem activates the expression of secreted toxins and inhibits
genes involved in biofilm formation. Yet, the decreased biofilm
formation and increased toxin secretion in W suggested that
the agr pathway had become active (see Figure 2B). The differ-
ential activation of the QS system was explored by the global1062 Cell 158, 1060–1071, August 28, 2014 ª2014 Elsevier Inc.gene expression profiling using RNA-
sequencing (RNA-seq) for the O, W,
and Y strains (Figure S3A and Table S3).
Comparison of the O and W gene ex-
pression signatures revealed hyperacti-
vated expression of the agr QS system
in W compared to O (Figures 2A and
S3B), which occurred concomitantly with
enhanced expression of a number of
agr-regulated genes. Activation of QS in
W is associated with hyperproduction of
the autoinducing peptidic pheromone
(AIP). At the threshold concentration, AIP
binds to its membrane-bound receptor
AgrC and triggers a QS response in
S. aureus (Novick and Geisinger, 2008;
MDowell et al., 2001; Thoendel et al.,2011). We genetically engineered a synthetic Bacillus subtilis
strain to express a fluorescent AIP-responsive reporter (Figures
S3C–S3G). Diluted supernatants of O, W, and Y strains were
added to cultures of the B. subtilis reporter strain. Supernatants
from W contained more AIP than those from O or Y (Figure 3A).
The phenotypic and transcriptional changes found in the W
strain were consistent with a sB loss-of-function mutation. The
stress-induced sigma factor sB strongly represses agr and in-
duces staphyloxanthin production (Bischoff et al., 2001; Kullik
et al., 1998), which would explain the high-expression agr and
the lack of pigmentation in W strain (Figure 2B). To test this,
we used qRT-PCR analysis to monitor two agr-dependent RNAII
and RNAIII transcripts (Novick and Geisinger, 2008; Thoendel
et al., 2011). RNAII and RNAIII were highly expressed in the W
strain compared with the O strain, which is consistent with
increased agr expression in W (Figure 3B). RNAII activates the
agrBDCA operon that encodes the agr regulatory cascade (Bis-
choff et al., 2001, 2004), which regulates the expression of the
surfactant phenol-soluble modulins (PSMs) (Queck et al.,
2008). RNAIII activates agr-dependent genes such as hla (Mor-
feldt et al., 1995, 1996) (Figure 2B). Consistent with a sB-defi-
cient phenotype, both psms and hla were highly expressed in
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Figure 2. Correlation of Genome-wide Gene
Expression Levels Quantified by RNA-Seq
(A) Read coverage of the agr gene cluster in O, W,
and Y. The expression of agr in W is increased
20-fold in relation to O.
(B) Schematic overview of the genetic circuitry that
antagonistically regulates toxin secretion and bio-
film formation in S. aureus. Arrows are positive
regulation, and T bars are repression. Dashed line
is indirect regulation. Staphyloxanthin production
is STX, and GSG are general stress genes. Tran-
scriptional activation in W is represented in green,
and downregulation is represented in red.
(C) Read coverage of the bsa gene cluster in O, W,
and Y cells. The expression of the bsa in W strain is
increased 300-fold in relation to O strain.
See Figure S3 and Tables S3, S4, and S5.the W strain (Figure 3B). We therefore searched for adaptive
mutations that would produce a sB-deficient phenotype by
sequencing the sigB operon (rsbU-rsbV-rsbW-sigB) (Figure S4A)
in nine different W strains derived from three independent evolu-
tion experiments. In each case, we found key point mutations in
an essential residue for the kinase activity of the RsbW antisigma
factor (Figures S4A, ii, and S4B). RsbW binds to and prevents sB
binding to the RNA polymerase. RsbW is also sequestered by
RsbV. Phosphorylation of RsbV by RsbW releases RsbW to
bind to and inhibit sB (Marles-Wright and Lewis, 2010) (Fig-
ure S4A). The mutation in RsbW inhibits its binding to RsbV,
generating a nonfunctional sB complex with RsbW (Dufour and
Haldenwang, 1994), possibly targeting it for degradation (Gra-
ham et al., 2013) (Figures S4C and S4D).
QS upregulates the production of secondary metabolites,
including antibiotics and PSMs surfactants (Table S4). This
included increased production of antibiotics that inhibited the
growth of O strain (see below) and PSMs surfactants that
enabled W to efficiently expand and rapidly colonize the plates
in a spreading assay (Figure 3C) (Tsompanidou et al., 2013)
and also in the biofilm formation assay (Figure 3E). The PSMs
were responsible for the increased spreading (Figures S4E–
S4G). Complementation of a sB-deficient laboratory strain with
the sB operon from W strains did not restore the WT phenotype,
which was rescued only by the sB operon from the O strain (Fig-
ure S4H). To demonstrate the evolutionary advantage of QS hy-
peractivation in W, we purified the AIP signal that triggers QS in
S. aureus from W cultures and added to the growth medium of
the O strain (MDowell et al., 2001). Activation of QS in W is asso-
ciated with hyperproduction of the AIP. Under these conditions,
the W or Y phenotypes were not observed (Figure 3D). To sum-
marize, W arises through a mutation that inhibits sB and causes
hyperactivation of QS, enabling the strain to both spread from
and inhibit the growth of the parental strain.
W Strain Produces Bsa Bacteriocin that Selects for the
Evolution of the Y Strain
To provide evidence for a growth advantage of W over O, a
growth assay was performed using a tractable CA-MRSA strain
(LAC) as a proxy O strain and aDsigBmutant asW strain. TheWTand DsigB strain were combined in a 5:1 ratio and grown in
TSBMg (5:1 is the empirically determined O:W ratio observed
upon initiation of diversification; Figure S2A). After incubation,
the synthetic communities recreated the phenotype previously
observed in the CA-MRSA colonies, with theWT strain restricted
to the origin and the QS-high strain (DsigB strain) rapidly expand-
ing and forming a white ring surrounding the colony (Figure 3E).
Thus, hyperactivation of the agrQS in the sB-deficient strain pro-
vided a growth advantage over the WT strain, enabling it to
rapidly spread. Importantly, the third yellow phenotype strain
that was not present in the original mixture also evolved during
the time course of the experiment. This third yellow strain radi-
ated from the WT sector in the center and grew through the
sB-deficient strain sector, similar to behavior of the Y phenotype
of the original CA-MRSA colonies.
The emergence of the Y strain after the W strain suggests that
the presence of Wmay be important for the evolution of Y strain.
As described above, phenotypic and transcriptomic data re-
vealed that the W strain produced several extracellular active
compounds. We detected high expression of a CA-MRSA-asso-
ciated gene cluster responsible for the production of the lantibi-
otic Bsa (bacteriocin of S. aureus) and its resistance machinery
(Figures 2C and S3B). Antibiotic-producing bacteria use antibi-
otics to remove niche competitors, and Bsa enables CA-MRSA
to compete with the natural flora of healthy individuals and facil-
itates the growth of CA-MRSAwhen coexisting with other bacte-
ria (Daly et al., 2010), thus indicating the potential of Bsa to act as
a selective pressure in the evolution of microbes.
Expression analysis of sB-deficient strain revealed an increase
in bsa expression, which was also dependent on agr (Kies et al.,
2003). As expected, W also showed higher expression of bsa-
related genes compared to O and Y (Figure 4A). Next, superna-
tants of O, W, and Y cultures were tested for antimicrobial activ-
ity against B. subtilis (Figures 4B and 4C). Supernatants from W
inhibited B. subtilis growth. Likewise, supernatants from sB-defi-
cient strains were toxic, and this toxicity was attenuated in the
absence of the agr or bsa gene clusters (Figures 4B and 4C).
The above experiments confirmed that the W strain produced
more Bsa antibiotic than O and Y strains (Table S4 and S5), but
it was unclear whether Bsa was responsible for the selectiveCell 158, 1060–1071, August 28, 2014 ª2014 Elsevier Inc. 1063
Figure 3. Adaptive Abilities of the W Strain
(A) Quantification of AIP in O,W, and Y supernatants
using a B. subtilis transducer strain and monitored
by flow cytometry (n = 50,000 events). Gray profile is
control with no supernatant added.
(B) qRT-PCR analysis of RNAII, RNAIII, and regu-
lated genes in different genetic backgrounds (Stu-
dent’s t test, p% 0.05).
(C) Spreading assay to monitor the ability of distinct
strains to expand on solid surfaces. Samples were
spotted and incubated for 24 hr at 37C. Multicel-
lular communities of distinct strains growing in
TSBMg for 5 days at 37C.
(D) Complementation of TSBMg with 5 mM AIP.
Plates were incubated at 37C for 5 days.
(E) Synthetic communities of different strain mix-
tures (ratio 5:1) were spotted in TSBMg and incu-
bated at 37C. YA strain differentiates after 5 days of
incubation. Scale bars, 1 mm.
See Figures S3, S4, and S6.pressure to generate the Y genotype. Addition of exogenous Bsa
to O, W, and Y cultures in TSB liquid medium strongly inhibited
the growth of O. Importantly, the addition of Bsa did not affect
the growth of W and minimally affected the growth of Y (Fig-
ure 4D, top row). Furthermore, in the syntheticmixed populations
(described above), deletion of the bsa cassette in a sB-deficient
strain did not prevent the rapid expansion of the sB-deficient
strain but prevented the emergence of the Y strain (Figure 5A,
top row). Likewise, the Y strain did not evolve from an O strain
lacking the bsa cluster (Figure 5B). Importantly, the addition of
exogenous Bsa to the O strain (grown on TSBMg agar) bypassed
the requirement for the W phenotype and Y flares directly
evolved from a growth-restricted O community in the absence
of W sectors (Figure 5A, bottom row). These results suggest an
important role for Bsa in the evolution of the Y phenotype.
Y Strain Shows a VISA-like Phenotype that Tolerates the
Presence of Bsa
Similar to many other antibiotics, Bsa is an epidermin-like anti-
biotic that targets lipid II during bacterial cell wall synthesis.1064 Cell 158, 1060–1071, August 28, 2014 ª2014 Elsevier Inc.Vancomycin also inhibits cell wall synthe-
sis by binding to the D-Ala-D-Ala residues
in the lipid-II-linked pentapeptide pre-
cursor of peptidoglycan (lipid-II-AA) (see
Figure S7A) (Howden et al., 2010). Vanco-
mycin has been consistently used to treat
MRSA infections. However, recently, the
emergence of strains that are intermedi-
ate resistant to vancomycin (VISA) (Hira-
matsu et al., 1997), as well as other cell
wall antibiotics, has been observed (Ca-
margo et al., 2008; Peleg et al., 2012).
VISA strains display increased cell wall
thickening, which reduces the access of
vancomycin to its lethal target (lipid-II-
AA) at the division septum (Figures S7A
and S7B). Interestingly, we find that
most sequenced VISA strains derivedfrom susceptible parental strains that do not contain the bsa
gene cluster (Figures S5A and S5B), which is similar to what
is seen in VRSA (Kos et al., 2012). Thus, the acquisition of the
VISA phenotype potentially enables Bsa-defective strains to
tolerate the presence of Bsa in mixed communities (Figure S5C)
because it has been recently reported that 30% of staphylo-
coccal infections involves colonization by multiple strains (Vo-
tintseva et al., 2014).
We explored the possibility that Y cells have acquired a VISA-
like phenotype to tolerate the presence of Bsa. Addition of van-
comycin to Y cultures revealed intermediate resistance (IR) to
vancomycin similar to their IR to Bsa (Figure 4D, bottom row).
In contrast, IR to vancomycin was not detected in W cultures,
which indicated that the VISA phenotype was specific to Y
strains. There are multiple pathways by which cells can acquire
a VISA phenotype. Nevertheless, mutations in graRS, vraRS,
and walKR two-component systems have been consistently
found in VISA isolates (Hafer et al., 2012; Howden et al., 2010).
To detect the existence of mutations that may confer a VISA-
like phenotype to Y, we performed a whole-genome sequence
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Figure 4. Adaptive Abilities of the Y Strain
(A) qRT-PCR analysis of the expression of bsa in distinct genetic backgrounds (Student’s t test, p% 0.05).
(B) Antimicrobial activity of filter-sterilized supernatants. 50 ml was used to supplement 1 ml cultures of B. subtilis. Growth inhibition prevented biofilm growth.
Negative and positive controls ( and +) represent B. subtilis cultures without and with kanamycin 5 mM.
(C) Quantification microbial survival (CFU/ml) in B. subtilis cultures conditioned with Bsa.
(D) Growth curves of O, W, and Y in TSB medium with different concentrations of Bsa or vancomycin (CFU/ml). Right panels show control growth curves of
isogenic VSSA/VISA strains (N315/Mu50) in the presence of different concentrations of Bsa or vancomycin.
See Figure S5.
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Figure 5. Y Strain Is a VISA-like Strain
(A) Progression of mixed LAC WT strain + LAC
DsigB Dbsa mutant in relation 5:1 (top). The com-
munities grew in TSBMg at 37C for 5 days. After
incubation, the community failed to develop Y
flares through the W sector. Progression of the O
strain in TSBMg at 37C for 5 days when supple-
mented with previously purified Bsa (6 mM)
(lower row). YB strain differentiates. Scale bar,
1 mm.
(B) Progression of the O strain Dbsa mutant in
TSBMg at 37C for 5 days. After incubation, the
community failed to develop Y flares through the
W sector.
(C) qRT-PCR analysis of several VISA-related
genes (ssaA, sle1, dltA murZ, and sgtB) in O, Y
strains and YA and YB strains derived from the
artificial mixture WT+DsigB (Figure 3G) and Bsa
supplementation (Figure 5A), respectively (Stu-
dent’s t test, p% 0.05).
(D) Quantification of bacterial survival in response
to lysostaphin treatment (LS 10 mg/ml for 15 min at
37C).
(E) Quantification of bacterial survival in response
to lysostaphin and vancomycin treatment of
different strains in relation to Y strain.
See Figures S5 and S7 and Table S6.comparison between Y and O. This revealed mutations in the
GraRS and WalKR two-component systems (Figure S6B), which
were further confirmed by Sanger sequencing of nine indepen-
dent evolutionary events in different colonies. Importantly, amino
acid substitutions detected in these two-component systems
have been previously described in VISA isolates (Matsuo et al.,
2013). The agr operon was sequenced as a control to confirm
that no mutations occurred in this locus. In addition, the Y strains
that evolved from the experiments of mixed communities (YA
strain shown in Figure 3E) or after exposure to Bsa (YB strain
shown in Figure 5A) were also sequenced. VISA-like mutations
were also found in the graRS, vraRS, and walKR operons in
both strains (Figure S6B).
GraRS, VraRS, and WalKR synergistically regulate a number
of genes involved in cell-wall synthesis. This stimulon is perma-
nently activated in VISA strains, which results in cell wall thick-
ening that reduces the access of vancomycin to its lethal target
lipid-II-AA at the division septum (Howden et al., 2010) (Figures
S7A and S7B). Gene expression analyses of VISA-related genes
confirmed the upregulation of cell-wall genes and downregula-
tion of autolysins in the different Y strains (Figures 5C and S5D).
Reduced diffusion of vancomycin to the septum was confirmed
in Y cells coupled to a thickening of the cell wall using electron
microscopy (Figures S7C–S7E) and reduced membrane sus-1066 Cell 158, 1060–1071, August 28, 2014 ª2014 Elsevier Inc.ceptibility to the endopeptidase lysosta-
phin (Sieradzki and Tomasz, 2003) (Fig-
ure 5D). In addition to this, the YA and
YB strains were more tolerant to the ac-
tion of lysostaphin than W cells and
were comparable to the natural Y strain
(Figure 5E). As expected, YA and YB
strains showed IR to vancomycin similarto the Y strain, suggesting a VISA-like phenotype (Figure 5E).
Complementation of a VSSA laboratory strain with the graRS,
vraRS, and walKR operons from different Y strains also resulted
in IR to vancomycin (Figure S5D). In sum, the production of Bsa
by W drives the evolution of the Y strain, which bears a striking
similarity to VISA isolates that have been described in the
clinics.
O, W, and Y Strains Also Evolve in In Vivo Infections
The emergence of two phenotypes from a MRSA isolate in vitro
demonstrates that clinically relevant properties can evolve solely
via competitive interactions within an MRSA colony biofilm.
However, it was unclear whether such biofilm-associated evolu-
tionary events could drive similar diversification in an in vivo
infection situation. Based on our in vitro data, we predicted
that regions of the body that are efficiently colonized by
S. aureus (cut-off R 105 colony forming units [CFU]/g of organ)
(Table S7) would coincide with the reservoirs of magnesium of
the body (i.e., bones and kidneys) (Gu¨nther, 2011; Jahnen-De-
chent, 2012), which would favor biofilm-like growth and the
emergence of the W and Y strains. Hence, a cohort of five
mice was infected with 107 CA-MRSA cells that were previously
grown in the absence of Mg2+ to prevent strain diversification
(Figure S2A). After 5 days of infection, mice were sacrificed
A B
C D
E
Figure 6. Diversification of S. aureus Com-
munities In Vivo
(A) Weight loss of infected BALB/c mice (n = 5)
during the course of the infection. Mice were in-
fected with 107 SC01 derivative previously grown
in TSB medium.
(B) Bacterial loads in the different organs counted
as CFU/g of organ.
(C) Quantification of the CFU of the distinct strains
in the organs that showed higher bacterial load
(R105 CFU/g).
(D) Survival curve of mice infected with O, W, or Y
strains. Cohorts of five mice were infected with 107
cells (in the case of O, W, and Y infections) or PBS
buffer as control. Mice were sacrificed when
showing severe symptoms of infections (descrip-
tion of symptoms is in the Extended Experimental
Procedures).
(E) Quantification of CFU/g of W and Y strains in
the organs of infected mice. A gray, dashed line
defines a cut-off number of 105 CFU/g to define
high and low bacterial load.
See Table S7.(Figure 6A), their organs collected, and the bacterial load
counted and examined for strain diversification (Figure 6B). We
detected low bacterial load (%105 CFU/g) in livers, spleens,
and hearts. Importantly, in these organs, the microbial commu-
nity was a homogenous population of the parental O phenotype
(data not shown). By contrast, the bacterial load in samples from
the bones, lungs, and kidneys was higher (R105 CFU/g) and
contained a heterogeneous mixture of O, W, and Y cells (Fig-
ure 6C). Y was the most abundant strain collected from kidneys
and bones, which are the two most important organs involved in
magnesium homeostasis (Jahnen-Dechent, 2012). The lungs
contained a higher proportion of W cells, which is consistent
with the high number of sB-deficient strains generally isolated
from lung infections (Karlsson-Kanth et al., 2006).
The O, W, and Y strains isolated from mice developed similar
biofilm morphologies to the strains from the diversification ex-
periments (Figure 7A). We tested three different W isolates
from lungs (Wm1), bones (Wm2), and kidneys (Wm3) for their ability
to spread, which occurred as previously described for the W
strain (Figure 7B). Further qRT-PCR analyses verified the upre-
gulation of RNAII and RNAIII and related genes (Figure 7C),
which is consistent with a sB-deficient phenotype in the Wm
strains. We sequenced the sigB operon in three different Wm iso-
lates from each organ (lungs, bones, and kidneys). One bone
isolate and one kidney isolate contained the same mutation inCell 158, 1060–1071rsbW that was identified in our diversifi-
cation experiment (D105N) (Figure S6A).
A third bone isolate contained I11L
mutation that generates an unstable
SigB protein (Karlsson-Kanth et al.,
2006) (Figure S6A). The other Wm strains
contained an 11 bp deletion of the 50
end of the rsbU gene, a frequently
observed mutation known to confer a
sB-deficient phenotype to diverse staph-ylococci (Herbert et al., 2010) (Figure S6A). Similarly, three
different Y strains isolated from lungs (Ym1), bones (Ym2), and
kidneys (Ym3) displayed IR to vancomycin and lysostaphin treat-
ment (Figure 7D). Further qRT-PCR analyses provided additional
evidence for a gene expression profile consistent with a VISA-
like phenotype (Figure 7E), and sequencing of graRS, vraRS,
and walKR operons from three different Ym isolates from lungs,
bones, and kidneys detected several mutations in graRS and
vraRS (Figure S6B). Altogether, these data provide multiple lines
of evidence that strain diversification also occurs in vivo in a
reproducible manner and generated similar phenotypes to those
observed in the laboratory.
Finally, we compared the infective potential of the O, W, and
Y strains that evolved in the laboratory experiment. To do this,
two cohorts of five mice were infected with 107 W or Y cells
previously grown in TSB medium, and the progression of the
infection was monitored. Remarkably, we observed higher viru-
lence in W and Y strains, manifested by the lower survival rate
of infected mice in comparison to infections with the parental
O strain (Figure 6D). The organs were collected, and their
bacterial load was counted. Accordingly, high bacterial load
(R105 CFU/g) was detected in almost all organs, suggesting
that, in contrast to the origin O strain, W or Y strains are more
prone to give rise to severe bacteremia in our infection model
(Figure 6E)., August 28, 2014 ª2014 Elsevier Inc. 1067
Figure 7. Adaptive Abilities of Wm and Ym Strains Diversified In Vivo
(A) Progression of the O, Wm, and Ym strains when growing in TSBMg for 5 days at 37
C. Scale bar, 1 mm.
(B) Spreading assay of distinct Wm strains.
(C) qRT-PCR of RNAII and RNAIII, RNAII-, and RNAIII-regulated genes psma and hla, bsa and repressed ica gene.
(D) Quantification of bacterial survival in response to lysostaphin and vancomycin treatment of different Ym strains. Values are presented in relation to Y strain.
(E) qRT-PCR analysis to monitor the differential expression of the VISA-related genes ssaA and sle1 autolysins, dltA, and cell wall turnovermurZ and sgtB genes
(Student’s t test, p% 0.05).
See Figures S6 and S7.
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DISCUSSION
There is a growing recognition of the importance of social inter-
actions for microbial communities (Nadell et al., 2009; West
et al., 2006). Growth under biofilm-like conditions places cells
in close proximity, which increases the potential for the pheno-
type of one cell to influence the evolution of other cells. In
particular, there is often strong competition for resources and
space that will favor strategies that enable one strain to sup-
press or outgrow another. Here, we have shown that these pro-
cesses can have a major impact on one of the world’s major
pathogens. Growing CA-MRSA cells under biofilm-promoting
conditions leads to an evolutionary arms race that begins
when the W strain evolves and utilizes the increased secretion
of PSMs and antibiotics to outcompete the WT O strain. How-
ever, the WT counter-adapts to this challenge and generates
the Y strain that can resist the secreted products of W. Our
assay utilizes a similar Mg2+ concentration to that found in
tissues in which staphylococcal infections become chronic
due to biofilm formation, such as bones (50 mM) or kidneys
(30 mM) and is equivalent to other conventional assays
(Beenken et al., 2003, 2004; Jahnen-Dechent, 2012). In addition
to this, it is known that the sequestration of Mg2+ from tissues
due to the use of tampons led to an outbreak of S. aureus-
induced toxic shock syndrome in women in the USA (Schlievert,
1985). Given these correlations between Mg2+ and S. aureus in-
fections, it is possible that Mg2+ acts upon the agr QS system
that reciprocally regulates biofilm formation and the secretion
of hemolytic toxins by a yet-unknown mechanism.
This assay revealed genetic diversification of a number of iso-
lates, being especially evident in a CA-MRSA strain isolated
from a hip wound (Tenover et al., 1994). The bone-associated
origin of this strain is possibly relevant in its predisposition to
diversify in our assay, which reflects the overwhelming inter-
strain variation that exists within staphylococcal isolates (Her-
bert et al., 2010).
The evolved W and Y phenotypes resemble those seen in the
clinics. sB-deficient strains such as the W strain are detected in
10% of staphylococcal infections (Lennette et al., 1985), and the
Y phenotype closely resembles VISA strains, which are currently
a major health problem, and suggests that VISA phenotypes can
emerge in a manner that is unrelated to vancomycin treatment.
Consistent with this, VISA strains have been observed in patients
with renal failure or infections of a prosthetic joint that have not
received vancomycin (Charles et al., 2004; Howden et al.,
2010; Jahnen-Dechent, 2012). Our work suggests that competi-
tion within biofilms can be central to understanding pathogenic
phenotypes and emphasizes the need to consider not only the
impact of treatment of bacterial infections but also the interac-
tions among the bacteria themselves.
EXPERIMENTAL PROCEDURES
Strains, Media, and Culture Conditions
The strain used for diversification was S. aureus derivative of Sc01 (Beenken
et al., 2003). Complete strain and plasmid lists are shown in Tables S1 and
S2. For biofilm formation in agar, an inoculum TSB plate was grown for 12 hr
at 37C. 2 ml of a cell suspension was spotted on the surface of TSBMg and
incubated at 37C for 5 days. When specified, 5 mM AIP was added. Bsawas added to different concentrations that are specified in the paper. Specific
growth conditions are presented in figure legends.
Conventional liquid-surface biofilm formation assays were performed in
TSB + glucose 0.5% + NaCl 3% (Beenken et al., 2003; Go¨tz, 2002). Secretion
of hemolytic toxins wasmonitored by spotting 3 ml of cultures in TSB 5%blood
agar plates and measuring the diameter size after incubating at 37C for 24 hr.
A protocol for staphyloxanthin purification was obtained fromPelz et al. (2005).
To assay spreading on solid surfaces, 2 ml of an overnight culture was spotted
on TSB 0.24%agar plates and incubated at 37C for 24 hr (Tsompanidou et al.,
2011). To assess resistance of cells to lysostaphin, cells were resuspended in
1 ml PBS and incubated for 15 min at 37C in the presence of lysostaphin
(10 mg/ml) (Cui et al., 2006) prior to dilution plating on TSB agar to determine
CFU/ml.
RNA Extraction and Analysis
O, W, and Y cultures were resuspended in RNA Protect (QIAGEN) and were
mechanically lysed using glass beads in a Fast Prep Shaker (two times; 45
s; speed, 6.5). The supernatants were used for RNA isolation using the RNeasy
mini kit (QIAGEN). The isolated RNA was treated with RNase-free DNase I to
remove DNA traces. The cDNA libraries were generated as described previ-
ously but omitting the RNA size-fractionation step prior to cDNA synthesis (Du-
gar et al., 2013). The libraries were sequenced with an Illumina HiSeq machine
with 100 cycles in single end mode. The demultiplexed files and coverages
files have been deposited in NCBI’s GEO database (GSE49636). For qRT-
PCR analysis, total RNA was reverse transcribed using hexameric random
primers, followed by qRT-PCR using SsoAdvanced SYBR Green Supermix
(BioRad) (primers listed in Table S2).
Mouse Infection Studies
All animal studies were approved by the local government of Franconia,
Germany (license number 55.2-2531.01-06/12) and performed in strict accor-
dance with the guidelines for animal care and experimentation. We used fe-
male BALB/c mice (16–18 g) (Charles River). S. aureus was cultured for 18 hr
at 37C on a TSB plate. Cells were diluted to the desired concentration and
validated by dilution plating in TSB agar. 100 ml S. aureus culture was injected
into the tail vein. 6 days after bacterial challenge, organs were aseptically har-
vested and the CFU determined. Organs were homogenized in 2 ml of sterile
PBS using Dispomix (Bio-Budget Technologies GmbH). Joints were ground
in a mortar prior homogenization. Serial dilutions of each organ were plated
on mannitol salt-phenol red agar plates and TSB plates and incubated at
37C for at least 48 hr. CFUs were counted, and the bacterial burden was
calculated as CFU/g of organ. To compare the infective potential of O, W,
and Y strains, three cohorts of fivemicewere infectedwith 100 mlS. aureus cul-
ture containing 107 cells injected into the tail vein. The infections were allowed
to progress until severe infections symptoms occurred or to an endpoint of
5 days. Organs were aseptically harvested, and the CFU was determined.
ACCESSION NUMBERS
The demultiplexed files and coverages files have been deposited in NCBI’s
GEO database under the accession number GSE49636.
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